StockData
Collegium Pharmaceutical, Inc logo

Collegium Pharmaceutical, Inc (COLL) stock

COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$25.43+0.11 (+0.43%)

Close on Nov 16, 2026Market cap $827.89MP/E 20.5Yield –

Collegium Pharmaceutical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Collegium Pharmaceutical's revenue for the twelve months ending Jun 30, 2026 was $808.21M, up 14.3% year over year. For fiscal 2025 it was $780.57M, up 23.6% from the year before. The highest annual figure on record is $780.57M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$780.57M+23.6%
FY2024Dec 31, 2024$631.45M+11.4%
FY2023Dec 31, 2023$566.77M+22.2%
FY2022Dec 31, 2022$463.93M+67.6%
FY2021Dec 31, 2021$276.87M-10.7%
FY2020Dec 31, 2020$310.02M+4.5%
FY2019Dec 31, 2019$296.70M+5.8%
FY2018Dec 31, 2018$280.41M+884.7%
FY2017Dec 31, 2017$28.48M+1564.3%
FY2016Dec 31, 2016$1.71M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$199.88M+6.3%
Q1 FY2026Mar 31, 2026$193.52M+8.9%
Q4 FY2025Dec 31, 2025$205.45M+12.9%
Q3 FY2025Sep 30, 2025$209.36M+31.4%
Q2 FY2025Jun 30, 2025$188.00M+29.4%
Q1 FY2025Mar 31, 2025$177.76M+22.7%
Q4 FY2024Dec 31, 2024$181.95M+21.5%
Q3 FY2024Sep 30, 2024$159.30M+16.5%
Q2 FY2024Jun 30, 2024$145.28M+7.2%
Q1 FY2024Mar 31, 2024$144.92M+0.1%
Q4 FY2023Dec 31, 2023$149.75M+15.5%
Q3 FY2023Sep 30, 2023$136.71M+7.6%
Q2 FY2023Jun 30, 2023$135.55M+9.7%
Q1 FY2023Mar 31, 2023$144.77M+72.9%
Q4 FY2022Dec 31, 2022$129.62M+373.7%
Q3 FY2022Sep 30, 2022$127.01M+61.1%
Q2 FY2022Jun 30, 2022$123.55M+49.0%
Q1 FY2022Mar 31, 2022$83.75M-4.5%
Q4 FY2021Dec 31, 2021$27.36M-64.1%
Q3 FY2021Sep 30, 2021$78.84M-0.4%
Q2 FY2021Jun 30, 2021$82.94M+6.3%
Q1 FY2021Mar 31, 2021$87.72M+14.7%
Q4 FY2020Dec 31, 2020$76.27M+2.8%
Q3 FY2020Sep 30, 2020$79.18M+8.5%
Q2 FY2020Jun 30, 2020$78.06M+4.0%
Q1 FY2020Mar 31, 2020$76.51M+2.7%
Q4 FY2019Dec 31, 2019$74.20M+1.1%
Q3 FY2019Sep 30, 2019$72.94M+3.9%
Q2 FY2019Jun 30, 2019$75.04M+2.7%
Q1 FY2019Mar 31, 2019$74.52M+16.9%
Q4 FY2018Dec 31, 2018$73.43M+580.3%
Q3 FY2018Sep 30, 2018$70.18M+487.2%
Q2 FY2018Jun 30, 2018$73.06M+1952.3%
Q1 FY2018Mar 31, 2018$63.75M+2835.0%
Q4 FY2017Dec 31, 2017$10.79M+728.4%
Q3 FY2017Sep 30, 2017$11.95M+2828.9%
Q2 FY2017Jun 30, 2017$3.56M–
Q1 FY2017Mar 31, 2017$2.17M–
Q4 FY2016Dec 31, 2016$1.30M–
Q3 FY2016Sep 30, 2016$408.00K–

More Collegium Pharmaceutical figures

See a number that looks wrong?